Device Trial Radar · NCT07649798
Initial Study of a MOTHER-DAUGHTER SIDE-BRANCH ACCESS™ DES System (FIH Feasibility Study)
Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
13
Actual
Start
Sep 16, 2025
Primary completion
Nov 19, 2025
Study completion Nov 19, 2028
Sponsor
- Lead sponsor
- Advanced Bifurcation Systems Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This first in human feasibility study is designed to evaluate the feasibility MD-SBA DES in subjects undergoing percutaneous coronary intervention (PCI) to treat bifurcation lesions.
Conditions
- Coronary Angioplasty
- Bifurcation Coronary Artery Disease
- Ischemic Heart Disease (IHD)
- Percutaneous Coronary Intervention (PCI)
Interventions
MD-SBA DES SystemDevice
The MD-SBA DES System is a single use, minimally invasive combination product that consists of a cobalt chromium metal coronary stent, coated with sirolimus in a PEA/BHT matrix, on a rapid exchange (RX) delivery system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedure SuccessTime frame: Periprocedural
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cirugía Cardiovascular, Sanatorio Italiano
Asunción, Paraguay
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.